Hosted by: Force Family Office
Fireside Chat: Treating the Root Cause of Psychiatric Disorders
Craig Shimasaki, PhD, MBA, President and CEO of Moleculera Biosciences and Rod Cotton, MBA, former C-suite executive with Roche and a Moleculera Board Member provide an overview of the company including its signature test, the Autoimmune Brain Panel and discuss other tests in development, such as the Autoimmune Cardiovascular Panel and Long-COVID Panel.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.